Search tips
Search criteria 


Logo of jmedgeneJournal of Medical GeneticsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Med Genet. 1995 December; 32(12): 976–978.
PMCID: PMC1051781

Phenylketonuria in a low incidence population: molecular characterisation of mutations in Finland.


The incidence of phenylketonuria (PKU) in Finland is extremely low, probably below 1 in 100,000. We describe the mutations and haplotypes in all four presently known patients. Mutation R408W was found on four mutant chromosomes (all haplotype 2), and IVS7nt1, R261Q, and IVS2nt1 were each found on a single chromosome. No mutation was found on the remaining chromosome. These findings support a pronounced negative founder effect as the cause of the low incidence of PKU in Finland, and are consistent with existing data regarding the European and Baltic origin of Finnish genes.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (580K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Corner EM, Grant L. Healed Double Empyema. Proc R Soc Med. 1912;5(CLIN):90–91. [PubMed]
  • Byck S, Morgan K, Tyfield L, Dworniczak B, Scriver CR. Evidence for origin, by recurrent mutation, of the phenylalanine hydroxylase R408W mutation on two haplotypes in European and Quebec populations. Hum Mol Genet. 1994 Sep;3(9):1675–1677. [PubMed]
  • Eisensmith RC, Goltsov AA, O'Neill C, Tyfield LA, Schwartz EI, Kuzmin AI, Baranovskaya SS, Tsukerman GL, Treacy E, Scriver CR, et al. Recurrence of the R408W mutation in the phenylalanine hydroxylase locus in Europeans. Am J Hum Genet. 1995 Jan;56(1):278–286. [PubMed]
  • Palo J. Prevalence of phenylketonuria and some other metabolic disorders among mentally retarded patients in Finland. Acta Neurol Scand. 1967;43(5):573–579. [PubMed]
  • Lidsky AS, Ledley FD, DiLella AG, Kwok SC, Daiger SP, Robson KJ, Woo SL. Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria. Am J Hum Genet. 1985 Jul;37(4):619–634. [PubMed]
  • Chakraborty R, Lidsky AS, Daiger SP, Güttler F, Sullivan S, Dilella AG, Woo SL. Polymorphic DNA haplotypes at the human phenylalanine hydroxylase locus and their relationship with phenylketonuria. Hum Genet. 1987 May;76(1):40–46. [PubMed]
  • Guldberg P, Henriksen KF, Güttler F. Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics. 1993 Jul;17(1):141–146. [PubMed]
  • Guldberg P, Romano V, Ceratto N, Bosco P, Ciuna M, Indelicato A, Mollica F, Meli C, Giovannini M, Riva E, et al. Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: implications for diagnosis of hyperphenylalaninemia in southern Europe. Hum Mol Genet. 1993 Oct;2(10):1703–1707. [PubMed]
  • Abrams ES, Stanton VP., Jr Use of denaturing gradient gel electrophoresis to study conformational transitions in nucleic acids. Methods Enzymol. 1992;212:71–104. [PubMed]
  • DiLella AG, Marvit J, Brayton K, Woo SL. An amino-acid substitution involved in phenylketonuria is in linkage disequilibrium with DNA haplotype 2. Nature. 327(6120):333–336. [PubMed]
  • Eisensmith RC, Okano Y, Dasovich M, Wang T, Güttler F, Lou H, Guldberg P, Lichter-Konecki U, Konecki DS, Svensson E, et al. Multiple origins for phenylketonuria in Europe. Am J Hum Genet. 1992 Dec;51(6):1355–1365. [PubMed]
  • Kleiman S, Bernstein J, Schwartz G, Eisensmith RC, Woo SL, Shiloh Y. A defective splice site at the phenylalanine hydroxylase gene in phenylketonuria and benign hyperphenylalaninemia among Palestinian Arabs. Hum Mutat. 1992;1(4):340–343. [PubMed]
  • Nevanlinna HR. The Finnish population structure. A genetic and genealogical study. Hereditas. 1972;71(2):195–236. [PubMed]
  • Nevanlinna HR. Genetic aspects of rare neurological diseases. Acta Neurol Scand Suppl. 1978;67:36–55. [PubMed]
  • Workman PL, Mielke JH, Nevanlinna HR. The genetic structure of finland. Am J Phys Anthropol. 1976 Mar;44(2):341–367. [PubMed]
  • de la Chapelle A. Disease gene mapping in isolated human populations: the example of Finland. J Med Genet. 1993 Oct;30(10):857–865. [PMC free article] [PubMed]
  • Norio R, Nevanlinna HR, Perheentupa J. Hereditary diseases in Finland; rare flora in rare soul. Ann Clin Res. 1973 Jun;5(3):109–141. [PubMed]
  • Hästbacka J, de la Chapelle A, Kaitila I, Sistonen P, Weaver A, Lander E. Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat Genet. 1992 Nov;2(3):204–211. [PubMed]
  • Hästbacka J, de la Chapelle A, Mahtani MM, Clines G, Reeve-Daly MP, Daly M, Hamilton BA, Kusumi K, Trivedi B, Weaver A, et al. The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell. 1994 Sep 23;78(6):1073–1087. [PubMed]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group